Ann Mullally
Associate Professor at Harvard Medical School
Schools
- Harvard Medical School
Links
Biography
Harvard Medical School
Clinical Interests
- Hematopoietic stem cells (HSC)
- Myeloid malignancies (primarily myeloproliferative neoplasms)
- Myeloproliferative neoplasms
Bio
Dr. Ann Mullally is a physician-scientist at Brigham and Women’s Hospital (BWH) / Dana-Farber Cancer Institute (DFCI). Her laboratory studies the genetics, biology and therapy of myeloproliferative neoplasms (MPN) using MPN patient samples, mouse models and multiple different laboratory approaches. Dr. Mullally’s MPN research interests include myelofibrosis, the biology of mutant calreticulin (CALR) in MPN, JAK2V617F MPN stem cells, improving the efficacy of JAK2 inhibitors and familial forms of MPN. The overarching goal of the research in her laboratory is to advance the understanding of the biology of MPN and to translate this into improved treatment options for patients dealing with these diseases.
Education
- MB BCh BAO University College Dublin (1993 — 1999)
Videos
Dr. Ann Mullally: A discussion about the new science to be presented at ASH 2016 - part 2
Dr. Ann Mullally - IMPACT@21
Module 1: Pre-MPN, Atypical MPNs, and Inflammation?
Ann Mullally is a new investigator looking to cure myelofibrosis
Ann Mullally, MD - Calreticulin Mutations in MPN
Preferentially Targeting the Malignant Hematopoietic Clone in Myeloproliferative Neoplasms (MPN)
Dr. Anne Mullally: A discussion about the new science to be presented at ASH 2016 - part 1
Conversations with Innovators: Ann Mullally, MD
Ann Mullally, MD: The Team and Tools for MPNs
Read about executive education
Other experts
Looking for an expert?
Contact us and we'll find the best option for you.